Pfizer Q3 PAT rises 1.6% YoY to Rs 141 cr

Image
Capital Market
Last Updated : Feb 08 2021 | 4:53 PM IST

Shares of Pfizer rose 0.58% to Rs 4542.75 after the drug company's net profit rose 1.6% to Rs 141.24 crore in Q3 FY21 from Rs 139.06 crore recorded in Q3 FY20.

The drug major's net sales grew by 10.3% to Rs 593.49 crore in Q3 FY21 from Rs 538.18 crore in Q3 FY20. The result was announced after market hours on Friday, 5 February 2021.

Profit before tax grew by 9.6% to Rs 180.26 crore in Q3 FY21 from Rs 164.50 crore in Q3 FY20. Current tax expense fell 8.8% to Rs 37.91 crore in Q3 FY21 over Q3 FY20.

Meanwhile, the company announced it has re-appointed S. Sridhar as the managing director of the company for a further period of five years with effect from 18 March 2021. The re-appointment of S. Sridhar will be subject to the approval of shareholders at the ensuing Annual General Meeting.

Pfizer is a research-based global biopharmaceutical company which is engaged in the discovery, development and manufacture of healthcare products.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 08 2021 | 11:44 AM IST

Next Story